Vivo Capital, LLC Aclaris Therapeutics, Inc. Call Options Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACRS
# of Institutions
98Shares Held
87.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$23.4 Million15.31% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$10.9 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.77MShares$7.82 Million0.46% of portfolio
-
Decheng Capital LLC Menlo Park, CA4.04MShares$6.63 Million1.45% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $109M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...